Fortis Healthcare Ltd (FORTIS) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Fortis Healthcare Ltd on NSE and BSE, with an AI summary of each filing.
The relevant disclosure is attached.
Others (Uncategorized) · 31 Oct 2026, 8:58 pm
Fortis Healthcare Announces Resignation of Chief Growth & Innovation Officer Fortis Healthcare Limited disclosed under Regulation 30 of SEBI Listing Regulations that Dr. Ritu Garg, Chief Growth & Innovation Officer and Senior Management Personnel, has resigned effective from the close of business hours on 31st Oct'26. The departure is attributed to an external professional opportunity pursued by the executive.
The relevant disclosure is attached.
Change in Management · 31 Oct 2026, 8:55 pm
Fortis Healthcare Announces Resignation of Chief Growth & Innovation Officer Dr. Ritu Garg Fortis Healthcare Limited has announced the resignation of Dr. Ritu Garg from her role as Chief Growth & Innovation Officer, designated as a Senior Management Personnel of the company. The resignation is effective from the close of business hours on 31st Oct'26. According to the regulatory disclosure under Regulation 30 of SEBI LODR Regulations, Dr. Garg has stepped down to pursue professional opportunities outside the organization.
The relevant disclosure is attached.
Others (Uncategorized) · 31 Oct 2026, 7:42 pm
Fortis Healthcare Announces Resignation of Chief Growth & Innovation Officer Fortis Healthcare Limited has announced the resignation of Dr. Ritu Garg from her role as Chief Growth & Innovation Officer and Senior Management Personnel, effective from the close of business hours on 31st Oct'26. According to the regulatory disclosure under SEBI Listing Regulations, Dr. Garg tendered her resignation to pursue an external professional opportunity and manage other commitments.
The relevant disclosure is attached
Change in Management · 31 Oct 2026, 7:39 pm
Fortis Healthcare Announces Resignation of Chief Growth & Innovation Officer Dr. Ritu Garg Fortis Healthcare Limited has informed stock exchanges that Dr. Ritu Garg, Chief Growth & Innovation Officer and Senior Management Personnel, tendered her resignation effective from the close of business hours on 31st Oct'26. The departure is attributed to her decision to pursue an external professional opportunity alongside other commitments and responsibilities.
The relevant disclosure is attached
Intimation · 06 Nov 2026, 11:00 am
Fortis Healthcare Schedules Q2FY27 and H1FY27 Earnings Conference Call Fortis Healthcare Limited has scheduled its post-results earnings conference call for Friday, 6th Nov'26, at 11:00 AM IST. The management will discuss the company's unaudited financial results for Q2FY27 and H1FY27 (quarter and half-year ended 30th Sep'26). The interaction will be conducted virtually via a group call format, accessible through domestic and international dial-in numbers. The company confirmed that no unpublished price-sensitive information (UPSI) will be shared during the meeting. A replay will remain available from 6th Nov'26 to 13th Nov'26.
To consider and approve the financial results for the period ended September 30, 2026 and other business matters
Intimation · 05 Nov 2026, 5:30 am
Fortis Healthcare Limited has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Alteration of form or nature or rights of securities/Alteration of date of payment of interest or redemption amount.
Intimation · 05 Nov 2026, 5:30 am
Fortis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Un-audited financial results ....
Intimation · 05 Nov 2026, 5:30 am
Fortis Healthcare Schedules Board Meeting for Q2 Earnings and Debenture Terms Alteration Fortis Healthcare's Board of Directors will meet on 5th Nov'26 to consider and approve standalone and consolidated un-audited financial results for the quarter and half-year ended 30th Sep'26. The board will also evaluate alterations to the rights, interest payment dates, and terms for 155,000 listed, senior, unsecured, rated, redeemable Non-Convertible Debentures aggregating up to INR 1,550 crore (face value INR 1,00,000 each). Consequently, the insider trading window remains closed until 7th Nov'26.
The relevant disclosure is attache.
Others (Uncategorized) · 29 Oct 2026, 12:48 am
Fortis Healthcare Acquires Bengaluru's Suguna Hospital for INR 277 Crores Fortis Healthcare, through its wholly-owned subsidiary International Hospital Limited, has acquired the business operations, land, and building of Bengaluru-based Suguna Ramaiah Hospitals via a slump sale for an all-cash consideration of ~INR 277 Cr on 28th Oct'26. The 110-bed facility generated FY26 revenue of INR 49.80 Cr (FY25: INR 49.90 Cr; FY24: INR 49.05 Cr) and holds expansion potential up to 150 beds. The acquisition strengthens Fortis' cluster presence in Bengaluru, expanding its city footprint to ~1,000 operational beds.
The relevant disclosure is attached.
Press Release · 29 Oct 2026, 12:42 am
Fortis Healthcare Acquires Bengaluru's Suguna Hospital for INR 277 Crore Fortis Healthcare, through its wholly-owned subsidiary International Hospital Limited, acquired the business operations, land, and building of Suguna Ramaiah Hospitals in Rajajinagar, Bengaluru, via a slump sale for approximately INR 277 crore in an all-cash deal consummated on 28th Oct'26. The 110-bed tertiary-care facility has expansion potential up to ~150 beds and generated ~INR 50 crore revenue in FY26 (INR 49.80 crore). The acquisition expands Fortis' operational capacity in Bengaluru to ~1,000 beds, strengthening its North-West corridor footprint alongside existing Rajajinagar and Yeshwanthpur facilities.
The relevant disclosure is attached
Others (Uncategorized) · 29 Oct 2026, 12:40 am
Fortis Acquires Suguna Hospital in Bengaluru for ₹277 Crore Fortis Healthcare, through its wholly-owned subsidiary International Hospital Limited, has acquired the business operations, assets, and underlying land and building of Bengaluru-based Suguna Hospital on a slump sale basis for ~₹277 cr in an all-cash deal consummated on 28th Oct'26. The 110-bed tertiary-care facility generated ₹49.8 cr in FY26 revenue and holds expansion potential up to ~150 beds. The strategic bolt-on acquisition expands Fortis's operational capacity in Bengaluru to ~1,000 beds, strengthening its North-West corridor cluster presence.
The relevant disclosure is attached.
Others (Uncategorized) · 12 Oct 2026, 9:30 pm
Fortis Healthcare Subsidiary to Acquire 26% Stake in Clean Max Sau for Captive Solar Power On 12th Oct'26, Fortis Healthcare Limited announced that its wholly owned subsidiary, Fortis Hospotel Limited, entered into an agreement to acquire a 26% equity stake in Clean Max Sau Private Limited for up to Rs 1.85 Cr in cash. The target SPV will develop, operate, and maintain a captive solar power generation project in Haryana. The investment aims to fulfill Fortis Hospotel's green energy requirements and optimize power costs, with the transaction expected to close within three months.
The relevant disclosure is attached.
Others (Uncategorized) · 12 Oct 2026, 7:12 pm
Fortis Healthcare Discloses ₹1,550 Crore Outstanding Privately Placed Debt Securities Fortis Healthcare reported details of its privately placed listed debt securities as of 30th Sep'26, comprising total outstanding debt of ₹1,550 crore across three tranches (₹500 crore, ₹500 crore, and ₹550 crore). Issued on 19th Dec'24 with maturity on 19th Dec'29, the instruments carry a Year 1 coupon of 7.7648% p.a. payable annually, subject to annual resets and step-up/step-down provisions.
The relevant disclosure is attached.
Press Release · 29 Sept 2026, 8:29 pm
IHH Reaffirms Fortis Commitment, Plans Stake Hike to 51% Amid Audit Following the Supreme Court of India's 25th Sep'26 disposal of Fortis Healthcare's SLP regarding a Delhi High Court-ordered forensic audit, IHH Healthcare confirmed full cooperation, reiterating its 2018 acquisition of a 31% stake for INR 4,000 crore followed standard regulatory and bidding protocols. IHH emphasized it had no involvement with former promoters or Daiichi Sankyo dispute proceedings. Strategically, IHH reaffirmed its India focus, planning to raise its Fortis stake to 51% over three to five years and expand capacity to ~10,000 beds by 2031.
The Detailed Disclosure on the facts, is attached.
Others (Uncategorized) · 27 Sept 2026, 4:41 pm
Supreme Court Allows Independent Forensic Audit for Fortis Healthcare The Supreme Court of India, vide order dated 25th Sep'26, disposed of Fortis Healthcare's Special Leave Petition challenging the Delhi High Court's 31st Aug'26 judgment. The apex court permitted the forensic audit to proceed but clarified that challenged High Court observations are tentative and that the audit must be conducted independently without their influence. Fortis confirmed that the High Court imposed no liability, penalty, or fine, maintaining it is an independent party to the Daiichi Sankyo–Singh Brothers dispute with promoter Northern TK Venture (IHH Healthcare).
The relevant disclosure is attached
Others (Uncategorized) · 25 Sept 2026, 7:10 pm
IHH Subsidiary NTK Appeals Tokyo District Court Judgment Over Daiichi Sankyo Dispute IHH Healthcare subsidiary and Fortis Healthcare promoter, Northern TK Venture (NTK), filed an appeal with the Tokyo High Court on 24th Sep'26 against the Tokyo District Court's 10th Sep'26 judgment regarding its dispute with Daiichi Sankyo. NTK claims damages from delayed mandatory tender offer approvals during its 2018 Fortis acquisition. Reaffirming its India commitment, IHH plans to raise its Fortis stake to 51% over the next 3-5 years, integrate Fortis with Gleneagles, and expand overall network capacity to ~10,000 beds by 2031.
The relevant disclosure is attached.
Press Release · 17 Sept 2026, 12:35 am
Fortis Healthcare Enters 29-Year Agreement for 400+ Bedded Delhi Hospital Fortis Healthcare's subsidiary, Fortis Hospotel Limited, signed a 29-year exclusive Healthcare Services Agreement on 16th Sep'26 with Seth Sunder Lal Jain Charitable Eye Hospital to provide medical services and equipment for an upcoming 400+ bedded super-specialty facility in Ashok Vihar, Delhi. FHTL will earn a revenue-share service fee and provide a construction loan of up to INR 567 Cr disbursed over 3-4 years. The project expands Fortis's Delhi-NCR footprint beyond 3,400 beds, with operations commencing in 3-4 years.
The relevant disclosure is attached.
Others (Uncategorized) · 17 Sept 2026, 12:32 am
Fortis Healthcare Signs 29-Year Agreement for 400+ Bed Hospital in New Delhi Fortis Healthcare's subsidiary, Fortis Hospotel, signed a 29-year exclusive agreement with Seth Sunder Lal Jain Charitable Eye Hospital to provide healthcare services for a new 400+ bed hospital in Ashok Vihar, New Delhi. Fortis will receive a revenue-share service fee and provide a loan up to INR 567 Cr in phased tranches over 3-4 years to fund construction and upgrades. Operations will commence in 3-4 years, expanding Fortis's Delhi-NCR network coverage to over 3,400 beds.
The relevant disclosure is attached.
Others (Uncategorized) · 16 Sept 2026, 4:31 pm
Fortis Healthcare Files Special Leave Petition Before Supreme Court Against Delhi High Court Order Fortis Healthcare has filed a Special Leave Petition before the Supreme Court of India on 16th Sep'26, challenging the Delhi High Court's judgment dated 31st Aug'26 in the matter of *Daiichi Sankyo Company, Limited vs. Malvinder Mohan Singh And Ors.* The petition pertains to execution applications EX.APPL.(OS) 3764/2022, EX.APPL.(OS) 1615/2025, and EX.APPL.(OS) 3763/2022. The company disclosed no immediate financial implications or claim quantums arising from the filing.
The Relevant Disclosure is Attached.
Intimation · 16 Sept 2026, 12:23 am
Fortis Healthcare Schedules In-Person Investor and Analyst Meetings in Mumbai Fortis Healthcare Limited will participate in two in-person group investor meetings in Mumbai from 9:00 AM to 6:00 PM IST. Management will attend a Non-Deal Roadshow organized by BNP Paribas on 21st Sep'26, followed by the J.P. Morgan India Conference organized by J.P. Morgan on 22nd Sep'26. The discussions will center on general business updates and industry trends, with no unpublished price-sensitive information being shared.
The Relevant Disclosure is Attached.
Intimation · 15 Sept 2026, 11:50 pm
Fortis Healthcare Schedules Institutional Investor Group Meetings in Mumbai Fortis Healthcare Limited will participate in in-person group investor meetings in Mumbai to discuss general business and industry updates. Management will attend a Non-Deal Roadshow organized by BNP Paribas on 21st Sep'26 from 9:00 AM to 6:00 PM IST, followed by the J.P. Morgan India Conference on 22nd Sep'26 during the same time slot. The company confirmed that no Unpublished Price Sensitive Information will be shared during these interactions.
The relevant disclosure is attached.
Others (Uncategorized) · 11 Sept 2026, 6:11 pm
Tokyo Court Dismisses Promoter Northern TK Venture's Litigation Against Daiichi Sankyo On 10th Sep'26, the Tokyo District Court dismissed all claims filed by Fortis Healthcare promoter Northern TK Venture Pte Ltd (NTK) against Daiichi Sankyo Company, Limited, directing NTK to bear the litigation costs. NTK, a subsidiary of IHH Healthcare Berhad, disagreed with the ruling and is reviewing the judgment alongside legal counsel to evaluate potential remedies and protect its interests through appropriate legal channels.
The relevant disclosure is attached.
Transcript · 10 Sept 2026, 8:36 pm
The revised Intimation is attached.
Intimation · 10 Sept 2026, 5:13 am
Fortis Healthcare Announces London Non-Deal Roadshow with IHH Healthcare Management Fortis Healthcare Limited and parent IHH Healthcare Berhad management will participate in an in-person, Non-Deal Roadshow organized by Jefferies in London on 14th Sep'26 and 15th Sep'26 (8:00 AM to 5:00 PM BST / 12:30 PM to 9:30 PM IST). The group meetings will focus on general business updates and industry dynamics. Fortis confirmed that no unpublished price-sensitive information (UPSI) will be discussed during the sessions.
The revised Intimation is attached.
Intimation · 10 Sept 2026, 5:09 am
Fortis Healthcare Announces London Non-Deal Roadshow with IHH Healthcare Management Fortis Healthcare Limited, alongside parent entity IHH Healthcare Berhad management, will participate in an in-person Non-Deal Roadshow organized by Jefferies in London on 14th Sep'26 and 15th Sep'26 (8:00 AM–5:00 PM BST / 12:30 PM–9:30 PM IST). The group meetings will focus on general industry dynamics and corporate business updates without sharing any Unpublished Price Sensitive Information (UPSI).